Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126967221 | 12696722 | 1 | I | 20160824 | 20160830 | 20160830 | EXP | DE-ROCHE-1822469 | ROCHE | PRIVACY. ANALYSIS OF CARDIOVASCULAR DISEASES AFTER THE UPLOAD PHASE WITH INTRAVITREAL RANIBIZUMAB AND BEVACIZUMAB IN PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION. DER OPHTHALMOLOGE ;:-. | 76.00 | YR | M | Y | 0.00000 | 20160830 | OT | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126967221 | 12696722 | 1 | PS | LUCENTIS | RANIBIZUMAB | 1 | Unknown | U | 125156 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126967221 | 12696722 | 1 | Neovascular age-related macular degeneration |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126967221 | 12696722 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126967221 | 12696722 | Cerebrovascular accident |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |